These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26117245)

  • 1. Association of Lecithin Cholesterol Acyltransferase rs5923 Polymorphism in Iranian Individuals with Extremely Low High-Density Lipoprotein Cholesterol: Tehran Lipid and Glucose Study.
    Naseri M; Hedayati M; Daneshpour MS; Bandarian F; Azizi F
    Iran Biomed J; 2015; 19(3):172-6. PubMed ID: 26117245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
    Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
    J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels.
    Naseri M; Hedayati M; Daneshpour MS; Bandarian F; Azizi F
    Mol Med Rep; 2014 Jul; 10(1):496-502. PubMed ID: 24789697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA polymorphism for lecithin:cholesterol acyltransferase (LCAT) is associated with high density lipoprotein cholesterol concentrations in baboons.
    Kammerer CM; Hixson JE; Mott GE
    Atherosclerosis; 1993 Jan; 98(2):153-63. PubMed ID: 8457258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons.
    Rainwater DL; Blangero J; Hixson JE; Birnbaum S; Mott GE; VandeBerg JL
    Arterioscler Thromb; 1992 Jun; 12(6):682-90. PubMed ID: 1350465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population.
    Tanaka SI; Fujioka Y; Tsujino T; Ishida T; Hirata KI
    Lipids Health Dis; 2018 Jul; 17(1):180. PubMed ID: 30055622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
    Haase CL; Tybjærg-Hansen A; Qayyum AA; Schou J; Nordestgaard BG; Frikke-Schmidt R
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E248-56. PubMed ID: 22090275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.
    Holleboom AG; Kuivenhoven JA; Peelman F; Schimmel AW; Peter J; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Motazacker MM
    Hum Mutat; 2011 Nov; 32(11):1290-8. PubMed ID: 21901787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
    Abd El-Aziz TA; Mohamed RH; Hagrass HA
    J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.
    Dullaart RP; Perton F; Kappelle PJ; de Vries R; Sluiter WJ; van Tol A
    Biochim Biophys Acta; 2010 Jan; 1801(1):84-8. PubMed ID: 19800416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men.
    Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ
    Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.
    Talmud PJ; Hawe E; Robertson K; Miller GJ; Miller NE; Humphries SE
    Ann Hum Genet; 2002 Mar; 66(Pt 2):111-24. PubMed ID: 12174215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature and severe cardiovascular disease in a Mexican male with markedly low high-density-lipoprotein-cholesterol levels and a mutation in the lecithin:cholesterol acyltransferase gene: a family study.
    Posadas-Sánchez R; Posadas-Romero C; Ocampo-Arcos WA; Villarreal-Molina MT; Vargas-Alarcón G; Antúnez-Argüelles E; Mendoza-Pérez E; Cardoso-Saldaña G; Martínez-Alvarado R; Medina-Urrutia A; Jorge-Galarza E
    Int J Mol Med; 2014 Jun; 33(6):1570-6. PubMed ID: 24715031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
    Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
    Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.